Article Information
History
- March 10, 2022.
Article Versions
- Version 1 (February 1, 2022 - 15:41).
- Version 2 (March 8, 2022 - 08:00).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chengxi Zang1,
- Hao Zhang1,
- Jie Xu2,
- Hansi Zhang2,
- Sajjad Fouladvand3,
- Shreyas Havaldar4,
- Feixiong Cheng5,6,7,
- Kun Chen8,
- Yong Chen9,
- Benjamin S. Glicksberg4,
- Jin Chen3,
- Jiang Bian2 and
- Fei Wang1,*
- 1Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA
- 2Department of Health Outcomes & Biomedical Informatics, University of Florida, Gainesville, FL, USA
- 3Institude for Biomedical Informatics (IBI) and Department of Computer Science, University of Kentucky, Lexington, KY, USA
- 4Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 5Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA
- 6Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA
- 7Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
- 8Department of Statistics, University of Connecticut, Storrs, CT, USA
- 9Department of Biostatistics, Epidemiology and Informatics (DBEI), the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- ↵*corresponding author: Fei Wang (few2001{at}med.cornell.edu)
Posted March 10, 2022.
High-Throughput Clinical Trial Emulation with Real World Data and Machine Learning: A Case Study of Drug Repurposing for Alzheimer’s Disease
